Cargando…

Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures

The ongoing COVID-19 pandemic drew global attention to infectious diseases, attracting numerous resources for development of pandemic preparedness plans and vaccine platforms—technologies with robust manufacturing processes that can quickly be pivoted to target emerging diseases. Newcastle Disease V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulber, Julia Puppin Chaves, Farnós, Omar, Kiesslich, Sascha, Yang, Zeyu, Dash, Shantoshini, Susta, Leonardo, Wootton, Sarah K., Kamen, Amine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623276/ https://www.ncbi.nlm.nih.gov/pubmed/34835266 http://dx.doi.org/10.3390/vaccines9111335

Ejemplares similares

Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
por: Kiesslich, Sascha, et al.
Publicado: (2021)

Vero cell upstream bioprocess development for the production of viral vectors and vaccines
por: Kiesslich, Sascha, et al.
Publicado: (2020)

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
por: Yang, Zeyu, et al.
Publicado: (2023)

Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
por: Fulber, Julia P. C., et al.
Publicado: (2022)

Haplotype-resolved de novo assembly of the Vero cell line genome
por: Sène, Marie-Angélique, et al.
Publicado: (2021)

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
por: Youssef, Maryam, et al.
Publicado: (2023)

Comparative Transcriptomic Analyses of a Vero Cell Line in Suspension versus Adherent Culture Conditions
por: Sène, Marie-Angélique, et al.
Publicado: (2023)

Only a small fraction of cells produce assembled capsids during transfection‐based manufacturing of adeno‐associated virus vectors
por: Dash, Shantoshini, et al.
Publicado: (2022)

Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub-Saharan Africa
por: Farnós, Omar, et al.
Publicado: (2020)

Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines
por: Yang, Zeyu, et al.
Publicado: (2022)

Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation
por: Farnós, Omar, et al.
Publicado: (2020)

Suspension culture of Vero cells for the production of adenovirus type 5
por: Lee, Deuk-Ki, et al.
Publicado: (2020)

Targeted Delivery of Chimeric Antigen Receptor into T Cells via CRISPR-Mediated Homology-Directed Repair with a Dual-AAV6 Transduction System
por: Moço, Pablo D., et al.
Publicado: (2023)

From functional genomics of vero cells to CRISPR‐based genomic deletion for improved viral production rates
por: Sène, Marie‐Angélique, et al.
Publicado: (2022)

Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
por: Santry, Lisa A., et al.
Publicado: (2017)

Titration methods for rVSV-based vaccine manufacturing
por: Gélinas, Jean-François, et al.
Publicado: (2020)

Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study
por: Lao, Thailin, et al.
Publicado: (2023)

Delayed Newcastle disease virus replication using RNA interference to target the nucleoprotein
por: Hutcheson, Jessica M., et al.
Publicado: (2015)

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model
por: Campbell, Elena S. B., et al.
Publicado: (2023)

Overcoming Barriers to Preventing and Treating P. aeruginosa Infections Using AAV Vectored Immunoprophylaxis
por: Lopes, Jordyn A., et al.
Publicado: (2022)

Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
por: Swiech, Kamilla, et al.
Publicado: (2011)

Production of Newcastle Disease Virus by Vero Cells Grown on Cytodex 1 Microcarriers in a 2-Litre Stirred Tank Bioreactor
por: Arifin, Mohd Azmir, et al.
Publicado: (2010)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
por: Warner, Bryce M., et al.
Publicado: (2021)

Whole-Genome Sequencing of Vero E6 (VERO C1008) and Comparative Analysis of Four Vero Cell Sublines
por: Konishi, Kazuhiro, et al.
Publicado: (2022)

Vectored-Vaccine Platforms Enabled Rapid Development of Safe and Effective Vaccines in Response to COVID-19 Pandemic Situation
por: Kamen, Amine A.
Publicado: (2021)

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media
por: Bauler, Matthew, et al.
Publicado: (2019)

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
por: McAusland, Thomas M., et al.
Publicado: (2021)

Tropism of Newcastle disease virus strains for chicken neurons, astrocytes, oligodendrocytes, and microglia
por: Butt, Salman L., et al.
Publicado: (2019)

Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
por: Dey, Sohini, et al.
Publicado: (2017)

Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery
por: Chahal, Parminder Singh, et al.
Publicado: (2014)

Derivation of chicken induced pluripotent stem cells tolerant to Newcastle disease virus-induced lysis through multiple rounds of infection
por: Susta, Leonardo, et al.
Publicado: (2016)

A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiency
por: Li, Changgui, et al.
Publicado: (2007)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Mucosal delivery of RNA vaccines by Newcastle disease virus vectors
por: García-Sastre, Adolfo
Publicado: (2022)

Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing
por: Tran, Michelle Yen, et al.
Publicado: (2022)

Critical Assessment of Purification and Analytical Technologies for Enveloped Viral Vector and Vaccine Processing and Their Current Limitations in Resolving Co-Expressed Extracellular Vesicles
por: Do Minh, Aline, et al.
Publicado: (2021)

Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
por: Vigil, Adam, et al.
Publicado: (2008)

Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines
por: Choi, Kang-Seuk
Publicado: (2017)

Impressioni dal vero : (1910-1911) : partitura d'orchestra
por: Malipiero, Gian Francesco, 1882-1973
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_3h6aiepa7nj2a7cfis3jjofa13